Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Notes Payables (2022 - 2025)

Updated

Analysis

Impact Biomedical (IBO) Notes Payables (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 22.88 Mn
Jun 30, 2025 22.35 Mn
Mar 31, 2025 9.14 Mn
Dec 31, 2024 8.88 Mn
Sep 30, 2024 35,000.00
Jun 30, 2024 13.45 Mn
Mar 31, 2024 12.79 Mn
Dec 31, 2023 12.07 Mn
Sep 30, 2023 11.78 Mn
Jun 30, 2023 11.75 Mn
Dec 31, 2022 9.99 Mn
API Access

Impact Biomedical Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IBO&period=max&api_key=YOUR_API_KEY